Berkowitz Noah's most recent trade in Arvinas Inc was a trade of 91,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arvinas Inc | Noah Berkowitz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 91,000 | 91,000 | - | - | Stock Option (right to buy) | |
| Arvinas Inc | Noah Berkowitz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 59,600 | 169,623 (0%) | 0% | 0 | Common Stock | |
| Arvinas Inc | Noah Berkowitz | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.59 per share. | 18 Mar 2025 | 8,658 | 110,023 (0%) | 0% | 8.6 | 74,372 | Common Stock |
| Arvinas Inc | Noah Berkowitz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 84,330 | 84,330 | - | - | Stock Option (right to buy) | |
| Arvinas Inc | Noah Berkowitz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 55,229 | 118,681 (0%) | 0% | 0 | Common Stock | |
| Arvinas Inc | Berkowitz Noah | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 93,879 | 93,879 | - | - | Stock Option (right to buy) | |
| Arvinas Inc | Berkowitz Noah | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 63,452 | 63,452 (0%) | 0% | 0 | Common Stock |